Since PP1A could affect ferroptosis and induce immune evasion through PD‐L1, we hypothesized that PP1A might bridge the ferroptosis and antitumor immunity in HCC TME, potentially enhancing the efficacy of combination therapy. This evidence concerns the gene CD274 and hepatocellular carcinoma.